Caribou Biosciences
Tina is the chief medical officer for Caribou Biosciences and is responsible for strategic leadership of the company’s clinical programs and the clinical, regulatory, and medical affairs functions. Tina brings 15 years of experience leading the development of cellular therapies and biologics. Previously, Tina was chief medical officer and head of development for Lyell Immunopharma, where she built and led the clinical development function and initiated two Phase 1 clinical trials evaluatin
Basic Information
- Category: Pharmaceuticals & Healthcare
- Founded: 2011
- Headquarters: Berkeley, CA
- Website: https://www.cariboubio.com
Documented Facts
- Founded: 2011 (No linked source recorded for this statement.)
- Headquarters: Berkeley, CA (No linked source recorded for this statement.)
- Category: Pharmaceuticals & Healthcare (No linked source recorded for this statement.)
- Phone: 510-982-6030 (No linked source recorded for this statement.)
- Email: careers@cariboubio.com (No linked source recorded for this statement.)
- CEO: and board chair (No linked source recorded for this statement.)
- Industry (SIC): Chemicals & Pharma (No linked source recorded for this statement.)
- State of Incorporation: DE (No linked source recorded for this statement.)
- Stock ticker: CRBU (Nasdaq) (No linked source recorded for this statement.)
Products and Services
- Caribou Biosciences Products: American biotechnology company.
Evidence and Sources
- Official Website (Primary Source)
- Caribou Biosciences on linkedin (social)
- Caribou Biosciences, Inc. — SEC EDGAR (reference)
Citation Guidance
Explore Pharmaceuticals & Healthcare profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Caribou Biosciences.
- Canonical profile: https://brandsource.ai/brands/caribou-biosciences
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/caribou-biosciences/json-ld
- Citation profile API: https://brandsource.ai/api/brands/caribou-biosciences/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (82/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2025-10-01
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Tina is the chief medical officer for Caribou Biosciences and is responsible for strategic leadership of the company’s clinical programs and the clinical, regulatory, and medical affairs functions. Tina brings 15 years of experience leading the development of cellular therapies and biologics. Previously, Tina was chief medical officer and head of development for Lyell Immunopharma, where she built and led the clinical development function and initiated two Phase 1 clinical trials evaluatin
Available profile information
- Official website is captured for entity disambiguation.
- 3 supporting sources linked.
- 9 structured facts available for extraction.
- 1 product or service signal captured.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.